Table 3. Comparison of demographics and percentage with known HIV-associated cancer cases between those with HIV(+) serology and those who met clinical criteria only.
| HIV Serology | |||||
| Patient Characteristics | Total(n = 171) | Initial HIV(+) Serology (n = 25) | Subsequent ConfirmedHIV(+) Serology (n = 22) | Total HIV(+)Serology | Clinical Criteria Only (n = 124) |
| Male sex | 59 (35%) | 14 (56%) | 10 (45%) | 24 (51%) | 35 (28%)* |
| Median age (range) in years | 39 (7–82) | 41 (7–61) | 39 (28–69) | 40 (7–69) | 39 (8–82) |
| Histological or cytological basis of diagnosis (otherwise in clinical chart) | 142 (83%) | 19 (76%) | 22 (100%) | 41 (87%) | 101 (81%) |
| Known HIV-associated tumor (i.e., KS, cervix, NHL, conjunctiva, and HD) | 118 (69%) | 17 (68%) | 18 (82%) | 35 (74%) | 83 (67%) |
[Notes: *Statistically significant difference (p = 0.005) between positive serology group (n = 47) and clinical criteria only group (n = 124) with respect to the patient characteristic (Chi-square test)].